Company intelligence / Profile preview

Event Cardio Group

Boynton Beach, Florida, United States

Ownership: Private
Development stage: Other

Overview

The company was developing a cardiac monitoring device that would collect medical data and transmit it to physicians for diagnostic evaluation. As of May 31, 2016, the device had not been completed and the company had not generated any revenue since inception.

Therapeutic areas: OncologyCardiovascular
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Medpac Asia Pacific (exclusive distribution agreement for BreastCare DTS and Now Cardio devices in Australia, New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Laos, Cambodia, Myanmar, and Bangladesh)

Beyond the preview

Go deeper on Event Cardio Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Event Cardio Group.

Explore the full profile